These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
188 related articles for article (PubMed ID: 36153483)
1. The immune subtypes and landscape of sarcomas. Weng W; Yu L; Li Z; Tan C; Lv J; Lao IW; Hu W; Deng Z; Liu Z; Wang J; Xu M BMC Immunol; 2022 Sep; 23(1):46. PubMed ID: 36153483 [TBL] [Abstract][Full Text] [Related]
2. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials. Zhu MMT; Shenasa E; Nielsen TO Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422 [TBL] [Abstract][Full Text] [Related]
3. Identification of tumor antigens and immune subtypes of cholangiocarcinoma for mRNA vaccine development. Huang X; Tang T; Zhang G; Liang T Mol Cancer; 2021 Mar; 20(1):50. PubMed ID: 33685460 [TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in Sarcoma: Current Data and Promising Strategies. Wood GE; Meyer C; Petitprez F; D'Angelo SP Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e432234. PubMed ID: 38781557 [TBL] [Abstract][Full Text] [Related]
5. Immune landscape of distinct subtypes in urothelial carcinoma based on immune gene profile. Peng M Front Immunol; 2022; 13():970885. PubMed ID: 36003383 [TBL] [Abstract][Full Text] [Related]
6. Association of Survival and Immune-Related Biomarkers With Immunotherapy in Patients With Non-Small Cell Lung Cancer: A Meta-analysis and Individual Patient-Level Analysis. Yu Y; Zeng D; Ou Q; Liu S; Li A; Chen Y; Lin D; Gao Q; Zhou H; Liao W; Yao H JAMA Netw Open; 2019 Jul; 2(7):e196879. PubMed ID: 31290993 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy for sarcomas. Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603 [TBL] [Abstract][Full Text] [Related]
8. Identification of Potential Antigens for Developing mRNA Vaccine for Immunologically Cold Mesothelioma. Zhang S; Li S; Wei Y; Xiong Y; Liu Q; Hu Z; Zeng Z; Tang F; Ouyang Y Front Cell Dev Biol; 2022; 10():879278. PubMed ID: 35846349 [TBL] [Abstract][Full Text] [Related]
9. Immune Subtypes and Immune Landscape Analysis of Endometrial Carcinoma. Liang L; Zhu Y; Li J; Zeng J; Yuan G; Wu L J Immunol; 2022 Oct; 209(8):1606-1614. PubMed ID: 36096644 [TBL] [Abstract][Full Text] [Related]
10. Identification of Tumor Antigens and Immune Subtypes for the Development of mRNA Vaccines and Individualized Immunotherapy in Soft Tissue Sarcoma. Wu C; Duan Y; Gong S; Osterhoff G; Kallendrusch S; Schopow N Cancers (Basel); 2022 Jan; 14(2):. PubMed ID: 35053609 [TBL] [Abstract][Full Text] [Related]
11. Dissecting Tumor Antigens and Immune Subtypes of Glioma to Develop mRNA Vaccine. Zhong H; Liu S; Cao F; Zhao Y; Zhou J; Tang F; Peng Z; Li Y; Xu S; Wang C; Yang G; Li ZQ Front Immunol; 2021; 12():709986. PubMed ID: 34512630 [TBL] [Abstract][Full Text] [Related]
12. The Immune Subtypes and Landscape of Gastric Cancer and to Predict Based on the Whole-Slide Images Using Deep Learning. Chen Y; Sun Z; Chen W; Liu C; Chai R; Ding J; Liu W; Feng X; Zhou J; Shen X; Huang S; Xu Z Front Immunol; 2021; 12():685992. PubMed ID: 34262565 [TBL] [Abstract][Full Text] [Related]
14. The Immune Subtypes and Landscape of Squamous Cell Carcinoma. Li B; Cui Y; Nambiar DK; Sunwoo JB; Li R Clin Cancer Res; 2019 Jun; 25(12):3528-3537. PubMed ID: 30833271 [TBL] [Abstract][Full Text] [Related]
15. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy? Atherton MJ; Lenz JA; Mason NJ Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517 [TBL] [Abstract][Full Text] [Related]
16. T-cell infiltration and clonality correlate with programmed cell death protein 1 and programmed death-ligand 1 expression in patients with soft tissue sarcomas. Pollack SM; He Q; Yearley JH; Emerson R; Vignali M; Zhang Y; Redman MW; Baker KK; Cooper S; Donahue B; Loggers ET; Cranmer LD; Spraker MB; Seo YD; Pillarisetty VG; Ricciotti RW; Hoch BL; McClanahan TK; Murphy E; Blumenschein WM; Townson SM; Benzeno S; Riddell SR; Jones RL Cancer; 2017 Sep; 123(17):3291-3304. PubMed ID: 28463396 [TBL] [Abstract][Full Text] [Related]
17. Clinical and translational implications of immunotherapy in sarcomas. Recine F; Vanni S; Bongiovanni A; Fausti V; Mercatali L; Miserocchi G; Liverani C; Pieri F; Casadei R; Cavaliere D; Falbo PT; Diano D; Ibrahim T; De Vita A Front Immunol; 2024; 15():1378398. PubMed ID: 38983859 [TBL] [Abstract][Full Text] [Related]
18. Targeted and immuno-based therapies in sarcoma: mechanisms and advances in clinical trials. Tang F; Tie Y; Wei YQ; Tu CQ; Wei XW Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188606. PubMed ID: 34371128 [TBL] [Abstract][Full Text] [Related]
19. Identification of the immune cell infiltration landscape in pancreatic cancer to assist immunotherapy. Wang Z; Zou W; Wang F; Zhang G; Chen K; Hu M; Liu R Future Oncol; 2021 Nov; 17(31):4131-4143. PubMed ID: 34346253 [TBL] [Abstract][Full Text] [Related]